个性化文献订阅>期刊> European Journal of Medicinal Chemistry
 

Molecular drug design, synthesis and crystal structure determination of Cu(II)-Sn(IV) heterobimetallic core: DNA binding and cleavage studies

  作者 Arjmand, F; Parveen, S; Afzal, M; Toupet, L; Ben Hadda, T  
  选自 期刊  European Journal of Medicinal Chemistry;  卷期  2012年49-1;  页码  141-150  
  关联知识点  
 

[摘要]A novel heterobimetallic Cu(II)-Sn(IV) complex 1 bearing bioactive 1,10-phenanthroline pharmacophore ligand scaffold was synthesized and characterized by elemental analysis, IR, UV-vis spectroscopy, Mass (ESI and FAB) and X-ray crystallography. The in vitro DNA binding studies of complex 1 with CT DNA was carried out by various biophysical and molecular docking techniques which revealed that complex 1 binds to DNA through intercalation in the minor groove having AT-rich sequences. Complex 1 exhibits high chemical nuclease activity cleaving supercoiled pBR322 DNA via hydrolytic pathway which was further evidenced by T4 DNA ligase assay. The complex 1 shows high inhibitory activity against Topo I at a very low concentration (15 mu M), suggesting that complex 1 is an efficient catalytic inhibitor of human Topo I and further validated by molecular docking studies. (C) 2012 Elsevier Masson SAS. All rights reserved.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内